YD Bio YDES
NASDAQ YDES
$6.22 +0.10 (+1.63%)
As of: Oct 20, 2026 · 12:30 PM EDT

YD Bio (YDES) Operating Leases (2024)

Updated

YD Bio (YDES) recorded Operating Leases of $5,684 in the quarter ended Dec 31, 2024.

Analysis

YD Bio (YDES) Operating Leases (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,156.90 Bn 1,125.48 Bn 19.71 Bn
2 Johnson & Johnson 623.56 Bn 542.09 Bn 17.26 Bn
3 AbbVie 511.45 Bn 484.57 Bn 12.70 Bn
4 Merck 365.96 Bn 320.33 Bn 12.21 Bn
5 Novartis Ag 297.17 Bn 261.16 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 234.28 Bn 189.68 Bn 7.24 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn
9 Pfizer 171.61 Bn 118.25 Bn 10.94 Bn
10 YD Bio 415.66 Mn 403.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5,684.00
API Access

YD Bio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=YDES&period=max&api_key=YOUR_API_KEY